Literature DB >> 19779677

[Malignant melanoma masquerading as a neurotrophic ulcer].

Larissa Schöttler1, Andreas Körber, Natalia Denisjuk, Julia Freise, Joachim Dissemond.   

Abstract

CASE REPORT: A 77-year-old female patient with an ulceration of the heel is described, which was treated over a period of 2 years as a neurotrophic ulcer related to diabetes mellitus. After the initial examination in the outpatient wound healing clinic, a malignant melanoma already showing invasive growth with a penetration depth of 4.6 mm was detected in a biopsy. After diagnosis and exclusion of metastases, a phase-adapted complete excision was carried out. Furthermore, an adjuvant immunotherapy was introduced.
CONCLUSION: Malignant melanoma is a primary cutaneous malignant tumor. Its thickness at the time of the initial diagnosis is crucial to the prognosis. Ulcerated and amelanotic melanomas still present a considerable clinical challenge due to the likelihood of being mistaken for benign diseases and the occurrence of filiae when diagnosis is made too late. This case report demonstrates the importance of differential diagnostic consideration of neoplasias, for example malignant melanoma, in cases of unclear, therapy-refractory wounds and discusses the relevant aspects in avoiding an unnecessary prolongation of diagnostics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779677     DOI: 10.1007/s00063-009-1155-y

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  8 in total

1.  Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.

Authors:  Petra G Buettner; Ulrike Leiter; Thomas K Eigentler; Claus Garbe
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

Review 2.  Current state of treatment for primary cutaneous melanoma.

Authors:  E S Chung; M S Sabel; V K Sondak
Journal:  Clin Exp Med       Date:  2004-10       Impact factor: 3.984

Review 3.  Epidemiology of cutaneous melanoma in Germany and worldwide.

Authors:  C Garbe; A Blum
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2001 Sep-Oct

Review 4.  Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence.

Authors:  Sylvie Bastuji-Garin; Thomas L Diepgen
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

Review 5.  Photobiology and genetics of malignant melanoma.

Authors:  Jean-Paul Ortonne
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

6.  Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factors.

Authors:  Dorothee Nashan; Burak Kocer; Meinhard Schiller; Thomas Luger; Stephan Grabbe
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 7.  Melanoma etiology: where are we?

Authors:  Margaret A Tucker; Alisa M Goldstein
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

Review 8.  [Therapy of malignant melanoma at the stage of distant metastasis].

Authors:  C Garbe; T K Eigentler
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

  8 in total
  1 in total

1.  [Plantar ulcer in a multimorbid patient].

Authors:  V Bekou; I Baltisser; R Dummer; J Traber
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.